Abstract
Retinoic acid receptor-beta (RAR-β) is nuclear receptor which can be activated by corresponding ligands, including retinoic acid. It is encoded by RARB gene, which is conserved in several species, and code for a DNA binding protein that in complex to the ligand and other binding partners binds to specific sites and regulates the expression of several genes. RAR-β plays important roles in several developmental, physiologic, and pathogenic mechanisms in human. It is a tumor suppressor gene, which is not expressed in several cancers. Methylation status and micro-RNAs are key central regulators of the RARB expression, which are influenced by several factors, such as environment and diet. It is responsible for the induction of apoptosis, and for the chemo-preventive and therapeutic effects of anti-cancer drugs, therefor has been used a treatment against different kinds of cancer in several clinical trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Al Tanoury Z, Piskunov A, Andriamoratsiresy D, Gaouar S, Lutzing R, Ye T et al (2014) Genes involved in cell adhesion and signaling: a new repertoire of retinoic acid receptor target genes in mouse embryonic fibroblasts. J Cell Sci 127(3):521–533
Allegrucci C, Rushton MD, Dixon JE, Sottile V, Shah M, Kumari R et al (2011) Epigenetic reprogramming of breast cancer cells with oocyte extracts. Mol Cancer 10(1):7. doi:10.1186/1476-4598-10-7
Chassaing N, Ragge N, Kariminejad A, Buffet A, Ghaderi-Sohi S, Martinovic J et al (2013) Mutation analysis of the STRA6 gene in isolated and non-isolated anophthalmia/microphthalmia. Clin Genet 83(3):244–250. doi:10.1111/j.1399-0004.2012.01904.x
Cheng AS, Li MS, Kang W, Cheng VY, Chou JL, Lau SS et al (2013) Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 144(1):122–133e129. doi:10.1053/j.gastro.2012.10.002
Chitayat D, Sroka H, Keating S, Colby RS, Ryan G, Toi A et al (2007) The PDAC syndrome (pulmonary hypoplasia/agenesis, diaphragmatic hernia/eventration, anophthalmia/microphthalmia, and cardiac defect) (Spear syndrome, Matthew-Wood syndrome): report of eight cases including a living child and further evidence for autosomal recessive inheritance. Am J Med Genet Part A 143A(12):1268–1281. doi:10.1002/ajmg.a.31788
Chung JH, Lee HJ, Kim BH, Cho NY, Kang GH (2011) DNA methylation profile during multistage progression of pulmonary adenocarcinomas. Virchows Arc: Internatl J Pathol 459(2):201–211. doi:10.1007/s00428-011-1079-9
Connolly RM, Nguyen NK, Sukumar S (2013) Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res 19(7):1651–1659
Cosialls AM, Santidrian AF, Coll-Mulet L, Iglesias-Serret D, Gonzalez-Girones DM, Perez-Perarnau A et al (2012) Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification. Epigenomics 4(5):491–501. doi:10.2217/epi.12.40
Dahl C, Christensen C, Jonsson G, Lorentzen A, Skjodt ML, Borg A et al (2013) Mutual exclusivity analysis of genetic and epigenetic drivers in melanoma identifies a link between p14 ARF and RARbeta signaling. Mol Cancer Res: MCR 11(10):1166–1178. doi:10.1158/1541-7786.MCR-13-0006
Dey A, Minucci S, Ozato K (1994) Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo. Mol Cell Biol 14(12):8191–8201
Dragnev KH, Rigas JR, Dmitrovsky E (2000) The retinoids and cancer prevention mechanisms. Oncologist 5(5):361–368
Durston A, Timmermans J, Hage W, Hendriks H, De Vries N, Heideveld M et al (1989) Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature 340(6229):140–144
Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P et al (2001) Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol 19(9):2456–2471
Gao T, He B, Pan Y, Li R, Xu Y, Chen L et al (2013) The Association of Retinoic Acid Receptor Beta2 (RARβ2) Methylation Status and Prostate Cancer Risk: A Systematic Review and Meta-Analysis. PloS ONE 8(5):e62950
Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG (1991) High frequency of retinoic acid receptor beta abnormalities in human lung cancer. Oncogene 6(10):1859–1868
Goljanek-Whysall K, Pais H, Rathjen T, Sweetman D, Dalmay T, Munsterberg A (2012) Regulation of multiple target genes by miR-1 and miR-206 is pivotal for C2C12 myoblast differentiation. J Cell Sci 125(Pt 15):3590–3600. doi:10.1242/jcs.101758
Gudas LJ, Sporn MB, Roberts AB (1994) Cellular biology and biochemistry of the retinoids. Retin Biol Chem Med 1994:443–520
Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J et al (2011) Prognostic significance of differentially expressed miRNAs in esophageal cancer. Internatl J Cancer J Internatl Du Cancer 128(1):132–143. doi:10.1002/ijc.25330
Inés FM, Gauna GV, Lis SM, Beatriz NS, Matias SA, María VRL (2014) Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor beta. J Cell Mol Med doi:10.1111/jcmm.12256.
Ivanova T, Petrenko A, Gritsko T, Vinokourova S, Eshilev E, Kobzeva V et al (2002) Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. BMC Cancer 2:4
Li M, Song S, Lippman SM, Zhang XK, Liu X, Lotan R et al (2002) Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene 21(3):411–418. doi:10.1038/sj.onc.1205106
Li RN, Yu FJ, Wu CC, Chen YK, Yu CC, Chou SH et al (2014) Methylation status of retinoic acid receptor beta2 promoter and global DNA in esophageal squamous cell carcinoma. J Surg Oncol 109(6):623–627
Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M et al (1996) Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16(3):1138–1149
Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ et al (1995) Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 332(21):1405–1410. doi:10.1056/NEJM199505253322103
Maden M (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8(10):755–765
Marchler-Bauer A, Bryant SH (2004) CD-Search: protein domain annotations on the fly. Nucl Acids Res 32(Web Server issue):W327–331. doi:10.1093/nar/gkh454
Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH et al (2009) CDD: specific functional annotation with the conserved domain database. Nucl Acids Res 37(Database issue):D205–210. doi:10.1093/nar/gkn845
Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C et al (2011) CDD: a Conserved Domain Database for the functional annotation of proteins. Nucl Acids Res 39(Database issue):D225–229. doi:10.1093/nar/gkq1189
Mark M, Ghyselinck NB, Chambon P (2009) Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 7:e002. doi:10.1621/nrs.07002.
Marzese DM, Hoon DS, Chong KK, Gago FE, Orozco JI, Tello OM et al (2012) DNA methylation index and methylation profile of invasive ductal breast tumors. J Mol Diagn 14(6):613–622. doi:10.1016/j.jmoldx.2012.07.001
Mehdipour P, Pirouzpanah S, Yam AA Retinoic Acid Receptor b2 Gene in Breast Cancer.
Mehdipour P, Pirouzpanah S, Azari Yam A (2012) Retinoic acid receptorb2 gene in breast cancer.Eur J Clin Med Oncol 4:17-33
Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P et al (1994) Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120(10):2749–2771
Molinari C, Casadio V, Foca F, Zingaretti C, Giannini M, Avanzolini A et al (2013) Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy? J Cell Physiol 228(12):2343–2349. doi:10.1002/jcp.24405
Niederreither K, Subbarayan V, Dollé P, Chambon P (1999) Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat Genet 21(4):444–448
Park SY, Kwon HJ, Choi Y, Lee HE, Kim SW, Kim JH et al (2012) Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes. Modern pathology: an official journal of the United States and Canadian academy of pathology. Inc 25(2):185–196. doi:10.1038/modpathol.2011.160
Pirouzpanah S, Taleban FA, Atri M, Abadi AR, Mehdipour P (2010) The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer. Cancer Causes Control: CCC 21(12):2101–2111. doi:10.1007/s10552-010-9629-z
Pirouzpanah S, Taleban FA, Mehdipour P, Atri M, Hooshyareh-Rad A, Sabour S (2013) The biomarker-based validity of a food frequency questionnaire to assess the intake status of folate, pyridoxine and cobalamin among Iranian primary breast cancer patients. Eur J Clin Nutr. doi:10.1038/ejcn.2013.209
Ribeiro IP, Marques F, Caramelo F, Ferrão J, Prazeres H, Julião MJ et al (2014) Genetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinoma-the first step towards clinical personalized medicine. Tumor Biology 35(5):4687–4695. doi: 10.1007/s13277-014-1614-9
Ross SA (2003) Diet and DNA methylation interactions in cancer prevention. Ann NY Acad Sci 983:197–207
Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K (1995) Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell growth & differentiation: the molecular biology journal of the American Association for. Cancer Res 6(9):1077–1088
Shen S, Kruyt FA, den Hertog J, van der Saag PT, Kruijer W (1991) Mouse and human retinoic acid receptor beta 2 promoters: sequence comparison and localization of retinoic acid responsiveness. DNA Seq: J DNA Seq Mapp 2(2):111–119
Sirchia SM, Ferguson AT, Sironi E, Subramanyan S, Orlandi R, Sukumar S et al (2000) Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Oncogene 19(12):1556–1563. doi:10.1038/sj.onc.1203456
Song S, Xu XC (2001) Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells. Biochem Biophys Res Commun 281(4):872–877. doi:10.1006/bbrc.2001.4433
Song S, Lippman SM, Zou Y, Ye X, Ajani JA, Xu XC (2005) Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression. Oncogene 24(56):8268–8276. doi:10.1038/sj.onc.1208992
Srour M, Chitayat D, Caron V, Chassaing N, Bitoun P, Patry L et al (2013) Recessive and dominant mutations in retinoic acid receptor beta in cases with microphthalmia and diaphragmatic hernia. Am J Hum Genet 93(4):765–772. doi:10.1016/j.ajhg.2013.08.014
Stefanska B, Karlic H, Varga F, Fabianowska-Majewska K, Haslberger A (2012) Epigenetic mechanisms in anti-cancer actions of bioactive food components-the implications in cancer prevention. Br J Pharmacol 167(2):279–297. doi:10.1111/j.1476-5381.2012.02002.x
Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A et al (1997) All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 337(15):1021–1028. doi:10.1056/NEJM199710093371501
Twelves D, Nerurkar A, Osin P, Dexter T, Ward A, Gui GP et al (2013) DNA promoter hypermethylation profiles in breast duct fluid. Breast Cancer Res Treat 139(2):341–350. doi: 10.1007/s10549-013-2544-8
Uray IP, Shen Q, Seo HS, Kim H, Lamph WW, Bissonnette RP et al (2009) Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1. J Biol Chem 284(1):345–353. doi:10.1074/jbc.M804721200
Veronesi U, Mariani L, Decensi A, Formelli F, Camerini T, Miceli R et al (2006) Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann Oncol 17(7):1065–1071
Wang Y, Fang MZ, Liao J, Yang GY, Nie Y, Song Y et al (2003) Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma. Clinical cancer research: an official journal of the American Association for. Cancer Res 9(14):5257–5263
Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI et al (2009) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137(6):2136–2145. e2137
Widschwendter M, Berger J, Muller HM, Zeimet AG, Marth C (2001) Epigenetic down regulation of the retinoic acid receptor-beta2 gene in breast cancer. J Mammary Gland Biol Neoplasia 6(2):193–201
Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L et al (2004) Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res Off J Am Assoc Cancer Res 10(5):1733–1742
Zanardi S, Serrano D, Argusti A, Barile M, Puntoni M, Decensi A (2006) Clinical trials with retinoids for breast cancer chemoprevention. Endocr-Relat Cancer 13(1):51–68
Zelent A, Mendelsohn C, Kastner P, Krust A, Garnier JM, Ruffenach F et al (1991) Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. EMBO J 10(1):71–81
Zhu GH, Huang J, Bi Y, Su Y, Tang Y, He BC et al (2009) Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differ Res Biol divers 78(4):195–204. doi:10.1016/j.diff.2009.06.001
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Fazilaty, H., Mehdipour, P. (2015). Retinoic Acid Receptor-β, From Gene to Clinic. In: Mehdipour, P. (eds) Epigenetics Territory and Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9639-2_12
Download citation
DOI: https://doi.org/10.1007/978-94-017-9639-2_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9638-5
Online ISBN: 978-94-017-9639-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)